Sophia Genetics SA Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on October 12, 2026 for $7.26 per share.
NASDAQ
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 4,000 shares of common stock on October 13, 2026 for $7.18 per share.
NASDAQ
Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 8,500 shares of common stock on October 12, 2026 for $7.26 per share.
NASDAQ
Well Daan Van, Chief Legal Officer of SOPHiA GENETICS SA, sold 6,168 shares of common stock on October 5, 2026 for $8.12 per share.
NASDAQ
Manuela Valente, Chief People Officer of SOPHiA GENETICS SA, sold 4,240 shares of common stock on October 5, 2026 for $8.13 per share.
NASDAQ
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA, sold 5,284 shares of common stock on October 5, 2026 for $8.12 per share.
NASDAQ
Kevin Puylaert, Chief Sales Officer of SOPHiA GENETICS SA, sold 216 shares of common stock on October 5, 2026.
NASDAQ
George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA, sold 1,592 shares of common stock on October 5, 2026 for $8.10 per share.
NASDAQ
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 7,394 shares of common stock on October 5, 2026 for $8.13 per share.
NASDAQ
Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 40,172 shares of common stock on October 5, 2026 for $8.13 per share.
NASDAQ
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 7,394 shares of common stock on October 5, 2026 for $8.12 per share.
NASDAQ
Ross Muken, Chief Executive Officer and a Director of SOPHiA GENETICS SA, sold 9,838 shares of common stock on October 5, 2026 for $8.13 per share.
NASDAQ
George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA, sold 774 shares of common stock on September 21, 2026 for $8.33 per share.
NASDAQ
Ross Muken, Chief Executive Officer and a Director of SOPHiA GENETICS SA, sold 422 shares of common stock on September 21, 2026 for $8.33 per share.
NASDAQ
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on September 14, 2026 for $7.88 per share.
NASDAQ
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 4,000 shares of common stock on September 14, 2026 for $7.88 per share.
NASDAQ
Well Daan Van, Chief Legal Officer of SOPHiA GENETICS SA, sold 6,168 shares of common stock on September 11, 2026 for $7.63 per share.
NASDAQ
Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 8,500 shares of common stock on September 10, 2026 for $7.66 per share.
NASDAQ
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 10,000 shares of common stock on August 27, 2026 for $8.91 per share.
NASDAQ
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on August 25, 2026 for $8.68 per share.
NASDAQ
Kathy L Hibbs, a Director of SOPHiA GENETICS SA, sold 6,250 shares of common stock on August 25, 2026 for $8.68 per share.
NASDAQ
Manuela Valente, Chief People Officer of SOPHiA GENETICS SA, sold 10,000 shares of common stock on August 19, 2026 for $7.94 per share.
NASDAQ
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 20,000 shares of common stock on August 19, 2026.
NASDAQ
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on August 12, 2026 for $7.52 per share.
NASDAQ
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 4,000 shares of common stock on August 13, 2026 for $7.52 per share.
NASDAQ
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on August 7, 2026 for $7.60 per share.
NASDAQ
Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 28,500 shares of common stock on August 7, 2026.
NASDAQ
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 20,000 shares of common stock on August 5, 2026.
NASDAQ
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares of common stock on July 27, 2026 for $5.66 per share.
NASDAQ
Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 44,381 shares of common stock on July 20, 2026.